Emergent BioSolutions Inc.

EBS· NYSE· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$6.78-3.42%

2026-09-18

Financials

Valuation Metrics

Emergent BioSolutions Inc.'s Market Cap is $350M. At end of 2025 it was $661M. Ranked #2902 of 3,121 in US market (top 93%), #1603 of 1,658 on NYSE (top 97%), #236 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 89%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$350M	US#2,902/3,121 Sec#236/266
Revenue	$770M	US#2,040/3,121 Sec#64/266
Net Income	$-177M	US—/3,121 Sec—/266
Total Assets	$1.12B	US#2,425/3,121 Sec#94/266
Net Assets	$341M	US#2,469/3,121 Sec#152/266
Value
P/B	1.02x	US#442/3,121 Sec#14/266
P/S	0.45x	US#297/3,121 Sec#5/266
FCF Yield	24.56%	US#123/3,121 Sec#5/266
Profitability
ROE	-51.79%	US#2,690/3,121 Sec#159/266
ROA	-15.83%	US#2,757/3,121 Sec#121/266
Op. Margin	-7.06%	US#2,514/3,121 Sec#90/266
Revenue Growth	-9.56%	US#2,598/3,121 Sec#147/266
Earnings Growth	-226.74%	US#1,970/3,121 Sec#63/266
Financial Health
Debt Ratio	227.12%	US#1,903/3,121 Sec#206/266
Total Debt	$582M	US#1,801/3,121 Sec#61/266
FCF	$86M	US#1,798/3,121 Sec#63/266
Cash	$140M	US#1,992/3,121 Sec#140/266
Current Ratio	5.42x	US#434/3,121 Sec#134/266
Performance
1Y Return	-14.61%	US#2,115/3,121 Sec#202/266
1M Return	38.65%	US#12/3,121 Sec#4/266
From 52W High	-51.78%	US#2,724/3,121 Sec#215/266
1Y MDD	-67.99%	US#2,927/3,121 Sec#234/266
Trading
Volume	893,156 shares	US#1,221/3,121 Sec#128/266
Trading Value	$6M	US#2,423/3,121 Sec#200/266
Per Share
EPS	$-3.43	US—/3,121 Sec—/266
BPS	$6.62	US#2,135/3,121 Sec#107/266